Assessment of Fluid Balance and the Approach to Fluid Therapy in the Perioperative Patient

Correlation Between Ultrasound-Measured Diameter and Blood Flow Velocity of the Internal Jugular Veins with the Preoperative Blood Volume in Elderly Patients

The study aimed to explore the correlation of the diameter and blood flow velocity of the internal jugular vein with the preoperative blood volume in elderly patients and to providence for rapid evaluation of preoperative blood volume with ultrasound in elderly patients. Thirty patients over 65 years old were recruited in the study. Patient’s central venous pressure (CVP) was recorded before anesthesia. The maximum diameter (Dmax) and the minimum diameter (Dmin) of the left internal jugular vein were measured by M type ultrasound and the respiratory variation index (RVI), defined as (Dmax − Dmin) / Dmax × 100%, was calculated. The maximum blood flow velocity (BVmax) and the minimum blood flow velocity (BVmin) were measured by Doppler ultrasound, and the blood flow variation index (BVI), defined as (BVmax − BVmin) / BVmax × 100%, was calculated. Then, each of the patients was given with 5 ml/kg crystalloid solution, and the relevant data were measured again and compared to that before infusion. The correlation between each measurement index and CVP, and their efficiency in predicting CVP > 6 mmHg were statistically evaluated. No matter before or after infusion, Dmax, Dmin, BVmax, and BVmin were positively correlated with CVP (Correlation is significant at the 0.01 level (2-tailed)); and RVI was negatively correlated with CVP (Correlation is significant at the 0.01 level (2-tailed)); however, BVI is negatively correlated with the CVP with no statistically significant difference. Through the analysis of ROC curve, Dmax, Dmin, RVI, BVmax, and BVmin could be used to predict the CVP > 6 mmHg in these patients, and the best index was BVmax; BVI diagnosis was not effective. Ultrasonic measurements of internal jugular vein diameter, respiratory variability, and blood flow velocity were correlated with preoperative CVP in elderly patients, indicating that these indexes could potentially be used to evaluate the preoperative blood volume in elderly patients.

Effectiveness of intravenous fluid resuscitation in hypotensive cats: 82 cases (2012-2019)

OBJECTIVE

To evaluate the effectiveness of intravenous fluid resuscitation in hypotensive cats in an emergency room setting. Secondary objectives were to investigate changes in heart rate (HR) and body temperature (BT) in response to fluid resuscitation, and the association of these changes with patient survival.

DESIGN

Retrospective study.

SETTING

University teaching hospital.

ANIMALS

Eighty-two cats with confirmed hypotension.

INTERVENTIONS

None.

MEASUREMENTS AND MAIN RESULTS

Medical records from 2012 to 2019 were searched for cats that had documented systemic arterial hypotension (blood pressure measured using a Doppler ultrasonic flow probe [DBP] < 90 mm Hg) on presentation to the emergency room. Data collected included patient characteristics and DBP, HR, and BT before and after fluid resuscitation, type and volume of fluids administered, and outcome. The median DBP before and after resuscitative fluid therapy in all cats was 65 mm Hg (range, 20-85 mm Hg) and 80 mm Hg (range, 20-128 mm Hg), respectively (P < 0.001). However, only 30 cats (37%) were classified as responders to fluid resuscitation (DBP ≥ 90 mm Hg following bolus therapy). The mean HR and median BT before resuscitative fluid therapy was 159/min and 36.7°C. Following fluid resuscitation, where measured, the mean HR and median BT was 154/min (P = 1.00) and 35.9°C (P = 1.00). No significant differences in HR and BT were identified between responders and non-responders. Cats had a low survival rate of 7%. All survivors (n = 5) were initially bradycardic (HR < 160/min), compared to only 45% of non-survivors (P = 0.4).

CONCLUSIONS

Bolus fluid resuscitation effectively increases blood pressure in hypotensive cats; however, it does not result in normalization of blood pressure, HR, or BT in the majority of cases.

Anesthesia-Associated Relative Hypovolemia: Mechanisms, Monitoring, and Treatment Considerations

Although the utility and benefits of anesthesia and analgesia are irrefutable, their practice is not void of risks. Almost all drugs that produce anesthesia endanger cardiovascular stability by producing dose-dependent impairment of cardiac function, vascular reactivity, and compensatory autoregulatory responses. Whereas anesthesia-related depression of cardiac performance and arterial vasodilation are well recognized adverse effects contributing to anesthetic risk, far less emphasis has been placed on effects impacting venous physiology and venous return. The venous circulation, containing about 65–70% of the total blood volume, is a pivotal contributor to stroke volume and cardiac output. Vasodilation, particularly venodilation, is the primary cause of relative hypovolemia produced by anesthetic drugs and is often associated with increased venous compliance, decreased venous return, and reduced response to vasoactive substances. Depending on factors such as patient status and monitoring, a state of relative hypovolemia may remain clinically undetected, with impending consequences owing to impaired oxygen delivery and tissue perfusion. Concurrent processes related to comorbidities, hypothermia, inflammation, trauma, sepsis, or other causes of hemodynamic or metabolic compromise, may further exacerbate the condition. Despite scientific and technological advances, clinical monitoring and treatment of relative hypovolemia still pose relevant challenges to the anesthesiologist. This short perspective seeks to define relative hypovolemia, describe the venous system’s role in supporting normal cardiovascular function, characterize effects of anesthetic drugs on venous physiology, and address current considerations and challenges for monitoring and treatment of relative hypovolemia, with focus on insights for future therapies.